- 26.
-
24Akiyama M, Sakai K, Wolff G, Hausser I, McMillan J, Sawamura D, Shimizu H: A novel ABCA12 mutation 3270delT causes harlequin ichthyosis.
Br J Dermatol 2006; 155(5): 1064-1066. - 25.
-
Mayuzumi M, Akiyama M, Nishie W, Ukae S, Abe M, Sawamura D, Hashimoto T, Shimizu H: Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature.
Br J Dermatol 2006; 155(5): 1048-1052. - 24.
-
Akiyama M, Sakai K, Sugiyama-Nakagiri Y, Yamanaka Y, McMillan JR, Sawamura D, Niizeki H, Miyagawa S, Shimizu H: Compound heterozygous mutations including a de novo missense mutation in ABCA12 led to a case of harlequin ichthyosis with moderate clinical severity.
J Invest Dermatol 2006; 126(7): 1518-1523. - 23.
-
Yokota K, Yamanaka Y, Furuya K, Sawamura D: Hailey-Hailey disease associated with affective disorder.
J Dermatol Sci 2006; 43(2): 150-151. - 22.
-
Goto M, Sawamura D, Nishie W, Sakai K, McMillan JR, Akiyama M, Shimizu H: Targeted skipping of a single exon harboring a premature termination codon mutation: Implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients.
J Invest Dermatol 2006; 126: 2614-2620. - 21.
-
Nakamura H, Sawamura D, Goto M, Nakamura H, Kida M, Ariga T, Sakiyama Y, Tomizawa K, Mitsui M, Tamaki T, Shimizu H: Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta.
Int J Mol Med 2006;18: 333-337. - 20.
-
Sawamura D, Mochitomi Y, Kanzaki T, Nakamura N, Shimizu H: Glycine substitution mutations of different amino acids at the same codon in COL7A1 cause different modes of dystrophic epidermolysis bullosa inheritance.
Br J Dermatol 2006; 155: 834-837. - 19.
-
Ujiie H, Sawamura D, Shimizu H: Development of lichen planus and psoriasis on lesions of vitiligo vulgaris.
Clin Exp Dermatol 2006; 31: 375-377. - 18.
-
Yasukawa K, Sawamura D, Jung Sung-Yong, Goto M, Nakamura H, Kim S-C, Shimizu H: Epidermolysis bullosa simplex in Oriental; genetic studies in 19 patients.
Br J Dermatol 2006; 155: 313-317. - 17.
-
Arita K, Akiyama M, Aizawa T, Umetsu Y, Segawa I, Goto M, Sawamura D, Demura M, Kawano K, Shimizu H: A Novel N14Y mutation in Connexin26 in keratitis-ichthyosis-deafness syndrome: analyses of altered gap junctional communication and molecular structure of N terminus of mutated Connexin26.
Am J Pathol 2006; 169(2): 416-423. - 16.
-
Sawamura D, Niizeki H, Miyagawa S, Shinkuma S, Shimizu H: A novel indel COL7A1 mutation 8068del17insGA causes dominant dystrophic epidermolysis bullosa.
Br J Dermatol 2006; 154: 995-997. - 15.
-
Sawamura D, Sato-Matsumura K, Shibata S, Tashiro A, Frue M, Goto M, Akiyama M, Nakamura H, Shimizu H: COL7A1 mutation G2037E causes epidermal retention of type VII collagen.
J Hum Genet 2006; 51: 418-420. - 14.
-
Onozuka T, Sawamura D, Goto M, Yokota K, Shimizu H: Possible role of endoplasmic reticulum stress in the pathogenesis of Darier’s disease.
J Dermatol Sci 2006; 41: 217-220. - 13.
-
Ota M, Sawamura D, Yokota Y, Ueda M, Horiguchi Y, Kodama K, Goto M, Shimizu H: A unique monoclonal antibody 29A staining the cytoplasm of amniotic epithelial in the placenta and cutaneous basement membrane zone.
J Dermatol Sci 2006; 42: 23-29. - 12.
-
Goto M, Sawamura D, Ito K, Abe M, Nishie W, Sakai K, Shibaki A, Akiyama M, Shimizu H: Fibroblasts show more potential target cells than keratinocytes for COL7A1 gene therapy of dystrophic epidermolysis bullosa.
J Invest Dermatol 2006; 126: 766-772. - 11.
-
Yanagi T, Sawamura D, Nishie W, Abe M, Shibaki A, Shimizu H: Multiple apocrine hidrocystoma showing plane pigmented macules.
J Am Acad Dermatol 2006; 54: S53-S54. - 10.
-
Tanimura S, Arita K, Iwao F, Kasai M, Fujita Y, Kawasaki H, Abe R, Sawamura D, Kimura T, Shimizu H: Two cases of folliculosebaceous cystic hamartoma the clinical and histopathologic differential points between folliculosebaceous cystic hamartoma and sebaceous trichofolliculoma.
Clin Exp Dermatol 2006; 31: 68-70. - 9.
-
Nakano H, Nakano A, Toyomaki Y, Ohashi S, Harada K, Moritsugu R, Takeda H, Kawada A, Mitsuhashi Y, Hanada K: Novel ferrochelatase mutations in Japanese patients with erythropoietic Protoporphyria: High frequency of the splice site modulator IVS3-48C polymorphism in the Japanese population.
J Invest Dermatol 2006; 126: 2717-2719. - 8.
-
Kondo N, Takeda H, Kaneko T, Aizu T, Moritsugu R, Kon A, Nakano H, Hanada K: A method for rapid evaluation of photoaging by measuring fluorescence intensity of green fluorescent protein due to elastin promoter activity.
J Dermatol Sci 2006: Suppl(2); 31-37. - 7.
-
Nishizawa A, Nakanishi Y, Sasajima Y, Yamazaki N, Yamamoto A: Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature.
Am J Dermatopathol 2006; 28(1): 56-59. - 6.
-
Ikenaga S, Nakano H, Umegaki N, Moritsugu R, Aizu T, Kuribayashi M, Hanada K： A case of bullous dermatitis artefacta possibly induced by a deodorant spray.
J Dermatol 2006; 33(1): 40-42. - 5.
-
Kaneko T, Tamai K, Matsuzaki Y, Yamazaki T, Nakano H, Kon K, Hashimoto I, Hanada K, Kaneda Y, Uitto J：Interferon-gamma down-regulates expression of the 230-kDa bullous pemphigoid antigen gene (BPAG1) in epidermal keratinocytes via novel chimeric sequences of ISRE and GAS.
Exp Dermatol 2006; 15(4): 308-314. - 4.
-
Jiang Q, Matsuzaki Y, Li K, Uitto J：Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene.
J Invest Dermatol 2006; 126: 325-335. - 3.
-
Nishizawa A, Nakanishi Y, Sasajima Y, Yamazaki N, Yamamoto A: Syringoid eccrine carcinoma with apparently aggressive transformation: case report and review of the literature.
International Journal of Dermatology 2006; 45: 1218-1221. - 2.
-
Kambe Y, Nakano H, Kaneko T, Aizu T, Ikenaga S, Harada K, Nakajima K, Moritsugu R, Hanada K: Giant pilomatricoma associated with hypercalcemia and elevated levels of parathyroid hormone-related protein.
Br J Dermatol 2006; 155: 208-210． - 1.
-
Nakano H, Ikenaga S, Aizu T, Kaneko T, Matsuzaki Y, Tsuchida S, Hanada K, Arima Y: Human metallothionein gene expression is upregulated by β-thujaplicin:possible involvement of protein kinase C and reactive oxygen species.
Biol Pharm Bull 2006; 29(1): 55-59．
